ATXN2 and Alzheimer disease: As suggested in the pathogenesis of Alzheimer’s disease (AD) and Parkinson’s disease (PD), it is reasonable to hypothesize that the progression of SCA2 may traverse the brain in a stepwise manner from one anatomical region to the next [122–124].